Nonalcoholic fatty liver disease and the renin-angiotensin system blockers in the patients with chronic kidney disease
详细信息 查看全文
- 作者：Lidija Orlic MD ; PhD ; Ivana Mikolasevic MD…
- 关键词：Renin ; angiotensin ; aldosteron system ; Nonalcoholic fatty liver disease (NAFLD) ; Chronic kidney disease ; Transient elastography ; Non ; invasive screening ; Renin ; Angiotensin ; Aldosteron System ; Nicht ; alkoholische Fettleber ; Chronische Nierenerkankung ; Transiente Elastographie ; Nicht ; invasives Screening
- 刊名：Wiener klinische Wochenschrift
- 出版年：2015
- 出版时间：May 2015
- 年：2015
- 卷：127
- 期：9-10
- 页码：355-362
- 全文大小：363 KB
- 参考文献：1.Cervera-Lizardi J, Zapata-Aguilar D. Nonalcoholic fatty liver disease and its association with cardiovascular disease. Ann Hepatol. 2009;8(1):S40鈥?.
2.Kim CH, Younossi ZM. Non alcoholic fatty liver disease: a manifestation of metabolic syndrome. Cleve Clin J Med. 2008;75:721鈥?.View Article PubMed
3.Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Disease, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55:2005鈥?3.View Article PubMed
4.Mikolasevic I, Racki S, Zaputovic l, Lukenda V, Milic S, Orlic L. Nonalcoholic fatty liver disease (NAFLD); a new risk factor for adverse cardiovascular events in dialysis patients. Med Hypothesis. 2014;82:205鈥?.View Article
5.Sasso M, Beaugrand M, dee Ledinghen V, et al. Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol. 2010;36(11):1825鈥?5.View Article PubMed
6.Wong GLH. Transient elastography: kill two birds with one stone? Word J Hepatol. 2013;5:264鈥?4.View Article
7.Mikolasevic I, Racki S, Lukenda V, Pavletic-Persic M, Milic S, Orlic L. Non-alcoholic fatty liver disease; a part of the metabolic syndrome in the renal transplant recipients and possible cause of an allograft dysfunction. Med Hypothesis. 2014;82:36鈥?.View Article
8.Targher G, Bertolini L, Rodella S, et al. Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis. Clin J Am Soc Nephrol. 2010;5:2166鈥?1.View Article PubMed Central PubMed
9.Hamad AA, Khalil AA, Connolly V, et al. Relationship between non-alcoholic fatty liver disease and kidney function: a communication between two organs that needs further exploration. Arab J Gastroenterol. 2012;13:161鈥?.View Article PubMed
10.Targher G, Chonchol M, Zoppini G, et al. Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link? J Hepatol. 2011;54:1020鈥?.View Article PubMed
11.Mikolasevic I, Racki S, Bubic I, Jelic I, Stimac D, Orlic L. Chronic kidney disease and nonalcoholic fatty liver disease proven by transient elastography. Kidney Blood Press Res. 2013;37:305鈥?0.View Article PubMed
12.Paschos P, Tziomalos K. Nonalcoholic fatty liver disease and the rennin-angiotensin system: implications for treatment. World J Hepatol. 2012;4:327鈥?1.PubMed Central PubMed
13.Abbas G, Silveira MG, Lindor KD. Hepatic fibrosis and the rennin-angiotensin system. Am J Ther. 2011;18:e202鈥?.View Article PubMed
14.Tobli JE, Munoz MC, Cao G, Mella J, Pereyra L, Mastai R. ACE inhibitors and AT1 blockade prevent fatty liver and fibrosis in obese Zucker rats. Obesity (Silver Spring). 2008;16:770鈥?.View Article
15.Pereira RM, dos Santos RAS, da Costa Dias FL, Teixeira MM, Simoes e Silva AC. Renin-angiotensin system in the pathogenesis of liver fibrosis. World J Gastroenterol. 2009;15:2579鈥?6.View Article PubMed Central PubMed
16.Hirata T, Tomita K, Kawai T, Yokoyama H, Shimada A, Kikuchi M, et al. Effect of telmisartan for treatment of nonalcoholic fatty liver disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY). Int J Endocrinol. 2013;2013 (Article ID 587140).
17.Grace JA, Herath CB, Mak KY, Burrell LM, Angus PW. Update on new aspects of the rennin-angiotensin system in liver disease: clinical implications and new therapeutic options. Clin Sci. 2012;123:225鈥?9.View Article PubMed
18.Toblli JE, De Rosa G, Rivas C, et al. Cardiovascular protective role of a low-dose antihypertensive combination in obese Zucker rats. J Hypertens. 2003;21:611鈥?0.View Article PubMed
19.Sun Y, Zhang J, Zhang JQ, Ramires FJ. Local angiotensin II and transforming growth factor 鈥?beta1 in renal fibrosis of rats. Hypertension. 2000;35:1078鈥?4.View Article PubMed
20.Bataller R, Sancho-Bru P, Gines P, Brenner DA. Liver fibrogenesis: a new role for the renin-angiotenzin system. Antioxid Redox Signal. 2005;7:1346鈥?5.View Article PubMed
21.Georgescu EF. Angiotensin receptor blockers in the treatment of NASH/NAFLD: could they be a first-class option? Adv Ther 2008;25:1141鈥?4.View Article PubMed
22.Libertato Oliveira IR Lopes Almeida EP Cavalcante Mattos MAG, et al. Liver enzymes in patients with chronic kidney disease undergoing peritoneal dialysis and hemodialysis. Clinics. 2012;67(2):131鈥?.View Article
23.Ono K, Ono T, Matsumata T. The pathogenesis of decreased aspartate amino-transferase and alanine aminotransferase activity in the plasma of hemodialysis patients: the role of vitamin B6 deficiency. Clin Nephrol. 1995;43:405鈥?.PubMed
24.Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotrasnferase levels. Ann Int Med. 2002;137:1鈥?.View Article PubMed
25.Day CP, James OF. Steatohepatitis: a tale of two 鈥渉its鈥? Gastroenterology. 1998;114:842鈥?.View Article PubMed
26.Dowman JK, Tomlinson JW, Newsome PN. Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2011;33:525鈥?0.View Article PubMed Central PubMed
27.Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis. 2007;191:235鈥?0.View Article PubMed
28.Gaia S, Carenzi S, Barilli AL, et al. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol. 2011;54:64鈥?1.View Article PubMed - 作者单位：Lidija Orlic MD, PhD (1)
Ivana Mikolasevic MD (1)
Vesna Lukenda MD (2)
Kata Anic MD (3)
Ita Jelic MD (1)
Sanjin Racki MD, PhD (1)
1. Department of Nephrology, Dialysis and Kidney Transplantation, University Hospital Center Rijeka, Tome Stri啪i膰a 3, 51000, Rijeka, Croatia
2. Department of Internal Medicine, General Hospital 鈥淒r. Josip Bencevic鈥? Slavonski Brod, Croatia
3. Infectious Disease Clinic, UHC Osijek, Osijek, Croatia - 刊物主题：Medicine/Public Health, general; Internal Medicine; Endocrinology; Gastroenterology; Pneumology/Respiratory System;
- 出版者：Springer Vienna
- ISSN：1613-7671
文摘